drugset / Trial / NCT02096458
Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to measure the in-vivo disintegration time of a single dexlansoprazole delayed-release orally disintegrating (OD) tablet.
Timeline
- Start
- 2014-02
- Primary completion
- 2014-02
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexlansoprazole | Other / unclassified | 30 mg | Oral |